help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2004-1429
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
90/2/992    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Carrillo-Vico, A.
Right arrow Articles by Guerrero, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Carrillo-Vico, A.
Right arrow Articles by Guerrero, J. M.
Related Collections
Right arrow Neuroendocrinology and Pituitary
The Journal of Clinical Endocrinology & Metabolism Vol. 90, No. 2 992-1000
Copyright © 2005 by The Endocrine Society

Human Lymphocyte-Synthesized Melatonin Is Involved in the Regulation of the Interleukin-2/Interleukin-2 Receptor System

Antonio Carrillo-Vico, Patricia J. Lardone, José M. Fernández-Santos, Inés Martín-Lacave, Juan R. Calvo, Michal Karasek and Juan M. Guerrero

Departments of Medical Biochemistry and Molecular Biology (A.C.-V., P.J.L., J.R.C., J.M.G.) and Normal and Pathological Cytology and Histology (J.M.F.-S., I.M.-L.), The University of Seville School of Medicine and Virgen Macarena Hospital, 41009 Seville, Spain; and Laboratory of Electron Microscopy (M.K.), Department of Pathology, Medical University of Lodz, 92-216 Lodz, Poland

Address all correspondence and requests for reprints to: Juan M. Guerrero, Department of Medical Biochemistry and Molecular Biology, The University of Seville School of Medicine, Avda. Sánchez Pizjuán 4, 41009 Seville, Spain. E-mail: guerrero{at}us.es.

Since melatonin was first isolated in 1958 up to the last few years, this substance was considered a hormone exclusive to the pineal gland. Although melatonin has lately been identified in a large number of extrapineal sites, its potential biological actions have not yet been studied. This paper shows that human lymphocyte-synthesized melatonin plays a crucial role modulating IL-2/IL-2 receptor system because when blocking melatonin biosynthesis by the tryptophan hydroxylase inhibitor, parachlorophenylalanine, both IL-2 and IL-2 receptor levels fell, restoring them by adding exogenous melatonin. Moreover, we demonstrated that this endogenous melatonin interfered with the exogenous melatonin effect on IL-2 production. Melatonin exerted these effects by a receptor-mediated action mechanism because both IL-2 and IL-2 receptor expressions significantly decreased when lymphocytes were incubated in the presence of the specific membrane and/or nuclear melatonin receptor antagonists, luzindole, and/or CGP 55644, respectively. Finally, we made the real significance of the membrane melatonin receptors in this process clear, so prostaglandin E2-induced inhibition on IL-2 production increased when we blocked the membrane receptors using luzindole. In conclusion, these data show that endogenous melatonin is an essential part for an accurate response of human lymphocytes through the modulation of IL-2/IL-2 receptor system.




This article has been cited by other articles:


Home page
J EndocrinolHome page
B. Roy, R. Singh, S. Kumar, and U. Rai
Diurnal variation in phagocytic activity of splenic phagocytes in freshwater teleost Channa punctatus: melatonin and its signaling mechanism
J. Endocrinol., December 1, 2008; 199(3): 471 - 480.
[Abstract] [Full Text] [PDF]


Home page
Integr Cancer TherHome page
V. Srinivasan, D W. Spence, S. R. Pandi-Perumal, I. Trakht, and D. P. Cardinali
Therapeutic Actions of Melatonin in Cancer: Possible Mechanisms
Integr Cancer Ther, September 1, 2008; 7(3): 189 - 203.
[Abstract] [PDF]


Home page
EndocrinologyHome page
A. J. Jimenez-Caliani, S. Jimenez-Jorge, P. Molinero, J. M. Fernandez-Santos, I. Martin-Lacave, A. Rubio, J. M. Guerrero, and C. Osuna
Sex-Dependent Effect of Melatonin on Systemic Erythematosus Lupus Developed in Mrl/Mpj-Faslpr Mice: It Ameliorates the Disease Course in Females, whereas It Exacerbates It in Males
Endocrinology, April 1, 2006; 147(4): 1717 - 1724.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
M Cutolo and G J M Maestroni
The melatonin-cytokine connection in rheumatoid arthritis
Ann Rheum Dis, August 1, 2005; 64(8): 1109 - 1111.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2005 by The Endocrine Society